Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
NRC Health Common Stock
NRC
$483M
| $18.5M | ﹤0.01% |
859,269
-142,611
| -14% | -$2.65M |
|
3152
Xeris Biopharma Holdings
XERS
$1.55B
| $18.5M | ﹤0.01% |
2,337,096
-235,558
| -9% | -$1.5M |
|
3153
Nuveen Municipal Credit Opportunities Fund
NMCO
$564M
| $18.5M | ﹤0.01% |
1,698,138
+121,194
| +8% | +$1.3M |
|
3154
iShares MSCI Poland ETF
EPOL
$841M
| $18.5M | ﹤0.01% |
478,851
-52,524
| -10% | -$2.06M |
|
3155
Boston Beer
SAM
$1.88B
| $18.5M | ﹤0.01% |
104,302
-30,209
| -22% | -$6.13M |
|
3156
Bank of N.T. Butterfield & Son
NTB
$2.33B
| $18.5M | ﹤0.01% |
310,108
-57,090
| -16% | -$3.23M |
|
3157
First Advantage
FA
$3.61B
| $18.4M | ﹤0.01% |
1,020,872
+269,867
| +36% | +$3.91M |
|
|
CSEN
3158
Cohen & Steers Future of Energy Active ETF
CSEN
$189M
| $18.4M | ﹤0.01% |
+778,673
| New | +$18.7M |
|
3159
First Trust Japan AlphaDEX Fund
FJP
$259M
| $18.4M | ﹤0.01% |
241,098
-2,482
| -1% | -$189K |
|
|
PDS
3160
Precision Drilling
PDS
$1.16B
| $18.4M | ﹤0.01% |
239,672
-5,523
| -2% | -$504K |
|
3161
Sixth Street Specialty
TSLX
$1.79B
| $18.4M | ﹤0.01% |
1,069,572
-258,043
| -19% | -$4.6M |
|
3162
Helix Energy Solutions
HLX
$1.49B
| $18.4M | ﹤0.01% |
2,100,464
+109,205
| +5% | +$1.05M |
|
3163
iShares Currency Hedged MSCI Emerging Markets
HEEM
$292M
| $18.4M | ﹤0.01% |
410,259
+49,126
| +14% | +$2.07M |
|
|
PDX
3164
PIMCO Dynamic Income Strategy Fund
PDX
$968M
| $18.3M | ﹤0.01% |
879,336
-35,462
| -4% | -$749K |
|
3165
SELLAS Life Sciences
SLS
$2.67B
| $18.2M | ﹤0.01% |
1,236,261
-100,032
| -7% | -$691K |
|
3166
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.67B
| $18.2M | ﹤0.01% |
255,165
+7,697
| +3% | +$522K |
|
3167
ProShares UltraPro QQQ
TQQQ
$36.2B
| $18.2M | ﹤0.01% |
224,748
+153,649
| +216% | +$10.7M |
|
|
BAND
3168
Bandwidth Inc
BAND
$1.58B
| $18.2M | ﹤0.01% |
286,837
+35,137
| +14% | +$1.58M |
|
3169
Compass Diversified
CODI
$861M
| $18.1M | ﹤0.01% |
1,702,535
-80,628
| -5% | -$880K |
|
3170
Central Garden & Pet Co Class A
CENTA
$2.37B
| $18.1M | ﹤0.01% |
468,036
+25,407
| +6% | +$887K |
|
3171
Amplify International Enhanced Dividend Income ETF
IDVO
$1.4B
| $18.1M | ﹤0.01% |
431,833
+431,376
| +94,393% | +$18.2M |
|
3172
Enerpac Tool Group
EPAC
$1.92B
| $18.1M | ﹤0.01% |
505,706
+25,413
| +5% | +$891K |
|
3173
Gentherm
THRM
$1.21B
| $18.1M | ﹤0.01% |
531,451
+83,036
| +19% | +$2.67M |
|
3174
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$904M
| $18.1M | ﹤0.01% |
416,811
+152,483
| +58% | +$6.64M |
|
3175
Spectrum Brands
SPB
$2.04B
| $18.1M | ﹤0.01% |
211,196
+41,344
| +24% | +$3.34M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.